Columbia team working on HIV prevention and treatment
Columbia Collaborative HIV/AIDS Clinical Trials Unit
A New York-based research group runs studies of vaccines, antibodies, and long-acting HIV medicines for people living with or at risk for HIV.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11238983 on NIH RePORTER |
What this research studies
This Columbia collaboration brings together experienced investigators and two clinic sites in New York City to run HIV prevention and treatment studies. You might be invited to try approaches such as vaccines, broadly neutralizing antibodies, long‑acting antiretroviral injections, or behavioral strategies to help with medication use. Some projects also look at tuberculosis, other health problems, and ways to keep people in care. Participation typically involves clinic visits, tests, and follow-up at the Columbia sites.
Who could benefit from this research
Good fit: Adults living with HIV or people at risk for HIV who can attend visits at the Columbia sites and are willing to join clinical research would be the ideal candidates.
Not a fit: People who are not living with or at risk for HIV, unable to travel to New York City clinics, or unwilling to take part in research visits are unlikely to benefit from this program.
Why it matters
Potential benefit: If successful, this work could lower the chance of getting HIV and expand treatment choices with longer‑lasting, easier regimens and better ways to support medication use.
How similar studies have performed: Previous trials have produced highly effective antiretroviral treatments and promising long‑acting drugs and antibodies, though some prevention approaches remain experimental.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Sobieszczyk, Magdalena Elzbieta — Columbia University Health Sciences
- Study coordinator: Sobieszczyk, Magdalena Elzbieta
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.